AAAAAA
Results:
1-7
|
Results: 7
Authors:
Boney, CM
Sekimoto, H
Gruppuso, PA
Frackelton, AR
Citation: Cm. Boney et al., Src family tyrosine kinases participate in insulin-like growth factor I mitogenic signaling in 3T3-L1 cells, CELL GROWTH, 12(7), 2001, pp. 379-386
Authors:
Boney, CM
Gruppuso, PA
Faris, RA
Frackelton, AR
Citation: Cm. Boney et al., The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes, MOL ENDOCR, 14(6), 2000, pp. 805-813
Authors:
Filardo, EJ
Quinn, JA
Bland, KI
Frackelton, AR
Citation: Ej. Filardo et al., Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF, MOL ENDOCR, 14(10), 2000, pp. 1649-1660
Authors:
Stevenson, LE
Ravichandran, KS
Frackelton, AR
Citation: Le. Stevenson et al., Shc dominant negative disrupts cell cycle progression in both G(0)-G(1) and G(2)-M of ErbB2-positive breast cancer cells, CELL GROWTH, 10(1), 1999, pp. 61-71
Authors:
Davol, PA
Frackelton, AR
Citation: Pa. Davol et Ar. Frackelton, Targeting human prostatic carcinoma through basic fibroblast growth factorreceptors in an animal model: Characterizing and circumventing mechanisms of tumor resistance, PROSTATE, 40(3), 1999, pp. 178-191
Authors:
Davol, PA
Bizuneh, A
Frackelton, AR
Citation: Pa. Davol et al., Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo, ANTICANC R, 19(3A), 1999, pp. 1705-1713
Authors:
Davol, PA
Garza, S
Frackelton, AR
Citation: Pa. Davol et al., Combining suramin and a chimeric toxin directed to basic fibroblast growthfactor receptors increases therapeutic efficacy against human melanoma in an animal model, CANCER, 86(9), 1999, pp. 1733-1741
Risultati:
1-7
|